Literature DB >> 9301354

Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection.

C D Inward1, M Varagunam, D Adu, D V Milford, C M Taylor.   

Abstract

The proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) interleukin (IL)-1 beta, IL-6, and IL-8 were measured in plasma and urine samples from 19 children with verocytotoxin-producing Escherichia coli (VTEC) induced haemolytic uraemic syndrome (HUS) and 30 controls. TNF-alpha was detected in the plasma of two cases and one control; IL-6 in the plasma of one, and the urine of two cases, and in the plasma of one control. IL-1 beta and IL-8 were each identified in eight of the 19 cases and in one and two controls respectively. Urinary IL-8 was found in seven cases, four of whom had plasma concentrations below the limit of detection suggesting renal secretion of this cytokine. Cytokine concentrations did not correlate with peripheral blood neutrophil count at onset of disease. These data confirm the systemic release of cytokines responsible for the coordination of acute inflammatory processes in some children with VTEC induced HUS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301354      PMCID: PMC1717278          DOI: 10.1136/adc.77.2.145

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Verocytotoxin-1 induces apoptosis in vero cells.

Authors:  C D Inward; J Williams; I Chant; J Crocker; D V Milford; P E Rose; C M Taylor
Journal:  J Infect       Date:  1995-05       Impact factor: 6.072

2.  Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

Authors:  D Karpman; A Andreasson; H Thysell; B S Kaplan; C Svanborg
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.

Authors:  A T Pavia; C R Nichols; D P Green; R V Tauxe; S Mottice; K D Greene; J G Wells; R L Siegler; E D Brewer; D Hannon
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

4.  Interleukin-8 primes human neutrophils for enhanced superoxide anion production.

Authors:  A Wozniak; W H Betts; G A Murphy; M Rokicinski
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

5.  Changes in the postenteropathic form of the hemolytic uremic syndrome in children.

Authors:  N A Coad; T Marshall; B Rowe; C M Taylor
Journal:  Clin Nephrol       Date:  1991-01       Impact factor: 0.975

6.  Plasma cytokine levels in hemolytic uremic syndrome.

Authors:  N C van de Kar; R W Sauerwein; P N Demacker; G E Grau; V W van Hinsbergh; L A Monnens
Journal:  Nephron       Date:  1995       Impact factor: 2.847

7.  Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.

Authors:  M M Fitzpatrick; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

8.  The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome.

Authors:  M D Walters; I U Matthei; R Kay; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

9.  Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina.

Authors:  E L López; M M Contrini; S Devoto; M F de Rosa; M G Graña; M H Genero; C Canepa; H F Gomez; T G Cleary
Journal:  Pediatr Infect Dis J       Date:  1995-07       Impact factor: 2.129

10.  Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis.

Authors:  T Wada; N Tomosugi; T Naito; H Yokoyama; K Kobayashi; A Harada; N Mukaida; K Matsushima
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  10 in total
  17 in total

1.  Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.

Authors:  Tiffany R Keepers; Lisa K Gross; Tom G Obrig
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

4.  Effect of enterohaemorrhagic Escherichia coli O157:H7-specific enterohaemolysin on interleukin-1β production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation.

Authors:  Yu-Li Cheng; Li-Qiong Song; Yuan-Ming Huang; Yan-Wen Xiong; Xiao-Ai Zhang; Hui Sun; Xin-Ping Zhu; Guang-Xun Meng; Jian-Guo Xu; Zhi-Hong Ren
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

5.  Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Hitoshi Irabu; Maiko Takakura; Hisashi Kaneda; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2017-03-10       Impact factor: 2.801

Review 6.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

7.  Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.

Authors:  Deborah J Stearns-Kurosawa; Valta Collins; Scott Freeman; Diann Debord; Kiyotaka Nishikawa; Sun-Young Oh; Caitlin S Leibowitz; Shinichiro Kurosawa
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

8.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

9.  Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Mao Mizuta; Naotoshi Sugimoto; Hisashi Kaneda; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2016-03-05       Impact factor: 2.801

10.  Hemolytic uremic syndrome: Events of the past decade.

Authors:  Peter N McLaine
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.